Abstract
Patients’ responses to quality-of-life questionnaires are dependent on the cultural milieu. The aims of this study were to translate the Irritable Bowel Syndrome Quality of Life questionnaire, which was developed in the West, into Korean and to validate the translated questionnaire in patients with irritable bowel syndrome. Translation of the original questionnaire was performed according to accepted linguistic validation guidelines. Korean patients had no difficulty understanding the questions. Data from the translated questionnaire were well correlated with results from the SF-36 questionnaire and reflected the stress status of the patients as measured on the Perceived Stress Scale. Some questionnaire items seemed, on first analysis, to be problematic in this subset of patients, but these results may relate, in part, to cultural differences between Korea and the West. We conclude that the translated questionnaire is reliable and offers an accurate measure of quality of life for Korean patients with irritable bowel syndrome.
Similar content being viewed by others
References
Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA (1999) Functional bowel disorders and functional abdominal pain. Gut 45(Suppl 2):ii43–ii47
Yacavone RF, Locke GR 3rd, Provenzale DT, Eisen GM (2001) Quality of life measurement in gastroenterology: What is available? Am J Gastroenterol 96:285–297
Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL (1998) Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 43:400–411
Bijkerk CJ, de Wit NJ, Muris JW, Jones RH, Knottnerus JA, Hoes AW (2003) Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol 98:122–127
Patrick DL, Wild DJ, Johnson ES, Wagner TH, Martin MA (1994) Cross-cultural validation of quality of life measures. In: Orley J, Kuyken W (eds). Quality of life assessment: international perspectives. Springer-Verlag, Berlin, pp 19–32
Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432
Ware JE, Kosinski M (2001) SF-36 physical & mental health summary scales: a manual for users of version 1, 2nd ed. QualityMetric, Lincoln, RI
Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385–396
Kamm MA (1999) Entry criteria for drug trials of irritable bowel syndrome. Am J Med 107:51S–58S
Staquet MJ, Hays RD, Fayers PM (1998) Quality of life assessment in clinical trials. In: Hunt SM (ed). Cross-cultural issues in the use of quality of life measures, Oxford University Press, New York, p 53
Sperber AD (2004) Translation and validation of study instruments for cross-cultural research. Gastroenterology 126(Suppl 1):S124–S128
Cho BL, Kim YS, Choi YS, Hong MH, Seo HG, Lee SY, Shin HC, Kim CH, Moon YS, Cha HS, Kim BS (2003) Prevalence and risk factors for erectile dysfunction in primary care: results of a Korean study. Int J Impot Res 15:323–328
Akehurst RL, Brazier JE, Mathers N, O’Keefe C, Kaltenthaler E, Morgan A, Platts M, Walters SJ (2002) Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics 20:455–462
Corney RH, Stanton R (1990) Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome. J Psychosom Res 34:483–491
Spiegel BM, Gralnek IM, Bolus R, Chang L, Dulai GS, Mayer EA, Naliboff B (2004) Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med 164:1773–1780
Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE (1998) Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 43:256–261
Drossman DA, Sandler RS, McKee DC, Lovitz AJ (1982) Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 83:529–534
Acknowledgements
This work was funded by grants to The Catholic University of Korea, College of Medicine, Seoul, Korea, by Novartis Pharmaceuticals Corporation, Korea. None of the authors own shares in Novartis Pharmaceuticals that constitute a conflict of interest in connection with this article. We thank Donald L. Patrick, for kindly consenting to let us use the IBS-QOL in Korea.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, J.M., Choi, MG., Oh, J.H. et al. Cross-Cultural Validation of Irritable Bowel Syndrome Quality of Life in Korea. Dig Dis Sci 51, 1478–1484 (2006). https://doi.org/10.1007/s10620-006-9084-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9084-6